{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:56:06Z","timestamp":1787165766485,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["8UL1TR000105"],"award-info":[{"award-number":["8UL1TR000105"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00408-021-00481-3","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T14:25:03Z","timestamp":1633011903000},"page":"517-525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Long-Term Treatment Outcomes after Behavioral Speech Therapy for Chronic Refractory Cough"],"prefix":"10.1007","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0030-8385","authenticated-orcid":false,"given":"Miranda L.","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna M.","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Herrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Barkmeier-Kraemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"issue":"5","key":"481_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.4168\/aair.2017.9.5.394","volume":"9","author":"WJ Song","year":"2017","unstructured":"Song WJ, Morice AH (2017) Cough hypersensitivity syndrome: a few more steps forward. Allergy Asthma Immunol Res 9(5):394\u2013402","journal-title":"Allergy Asthma Immunol Res"},{"issue":"9","key":"481_CR2","first-page":"1","volume":"1","author":"LP McGarvey","year":"2005","unstructured":"McGarvey LP (2005) Idiopathic chronic cough: a real disease or a failure of diagnosis? Cough 1(9):1\u20135","journal-title":"Cough"},{"issue":"1","key":"481_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1378\/chest.15-1496","volume":"149","author":"P Gibson","year":"2016","unstructured":"Gibson P, Wang G, McGarvey L et al (2016) Treatment of unexplained chronic cough: CHEST guideline and expert panel report. Chest 149(1):27\u201344","journal-title":"Chest"},{"key":"481_CR4","volume-title":"Speech pathology management of chronic refractory cough and related disorders","author":"A Vertigan","year":"2016","unstructured":"Vertigan A, Gibson P (2016) Speech pathology management of chronic refractory cough and related disorders. Compton Publishing, St. Giles"},{"issue":"10","key":"481_CR5","doi-asserted-by":"publisher","first-page":"e78081","DOI":"10.1371\/journal.pone.0078081","volume":"8","author":"WJ Song","year":"2013","unstructured":"Song WJ, Morice AH, Kim MH et al (2013) Cough in the elderly population: relationships with multiple comorbidity. PLoS ONE 8(10):e78081","journal-title":"PLoS ONE"},{"issue":"3","key":"481_CR6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1378\/chest.15-1271","volume":"149","author":"AE Vertigan","year":"2016","unstructured":"Vertigan AE, Kapela SL, Ryan NM et al (2016) Pregabalin and speech pathology combination therapy for refractory chronic cough: a randomized controlled trial. Chest 149(3):639\u2013648","journal-title":"Chest"},{"key":"481_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5590","author":"PG Gibson","year":"2015","unstructured":"Gibson PG, Vertigan AE (2015) Management of chronic refractory cough. BMJ. https:\/\/doi.org\/10.1136\/bmj.h5590","journal-title":"BMJ"},{"issue":"3","key":"481_CR8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1177\/0194599818768517","volume":"159","author":"AJ Bowen","year":"2018","unstructured":"Bowen AJ, Nowacki AS, Contrera K, Trask D, Kaltenbach J, Milstein CF, Adessa M, Benninger MS, Taliercio R, Bryson PC (2018) Short- and long-term effects of neuromodulators for unexplained chronic cough. Otolaryngology 159(3):508\u2013515","journal-title":"Otolaryngology"},{"issue":"7","key":"481_CR9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/14656566.2018.1462795","volume":"19","author":"NM Ryan","year":"2018","unstructured":"Ryan NM, Vertigan AE, Birring SS (2018) An update and systematic review on drug therapies for the treatment of chronic cough. Expert Opin Pharmacother 19(7):687\u2013711","journal-title":"Expert Opin Pharmacother"},{"key":"481_CR10","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/S0140-6736(12)60776-4","volume":"380","author":"NM Ryan","year":"2012","unstructured":"Ryan NM, Birring SS, Gibson PG (2012) Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet 380:1583\u20131589","journal-title":"Lancet"},{"issue":"3","key":"481_CR11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/cpt.2003","volume":"109","author":"SB Mazzone","year":"2021","unstructured":"Mazzone SB, McGarvey L (2021) Mechanisms and rationale for targeted therapies in refractory and unexplained chronic cough. Clin Pharmacol Ther 109(3):619\u2013636","journal-title":"Clin Pharmacol Ther"},{"key":"481_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000029232","volume":"65","author":"PV Dicpinigaitis","year":"1998","unstructured":"Dicpinigaitis PV, Rauf K (1998) Treatment of chronic, refractory cough with baclofen. Respiration 65:86\u201388","journal-title":"Respiration"},{"key":"481_CR13","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1097\/01.mlg.0000244377.60334.e3","volume":"116","author":"A Jeyakumar","year":"2006","unstructured":"Jeyakumar A, Brickman TM, Haben M (2006) Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy. Laryngoscope 116:2108\u20132112","journal-title":"Laryngoscope"},{"issue":"9853","key":"481_CR14","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/S0140-6736(12)60776-4","volume":"380","author":"NM Ryan","year":"2012","unstructured":"Ryan NM, Birring SS, Gibson PG (2012) Gabapentin for refractory chronic cough: a randomized, double-blind, placebo-controlled trial. Lancet 380(9853):1583\u20131589","journal-title":"Lancet"},{"key":"481_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pupt.2017.04.001","volume":"47","author":"SS Birring","year":"2017","unstructured":"Birring SS, Floyd S, Reilly CC et al (2017) Physiotherapy and speech and language therapy intervention for chronic cough. Pulm Pharmacol Ther 47:84\u201387","journal-title":"Pulm Pharmacol Ther"},{"issue":"6","key":"481_CR16","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.jaip.2019.03.030","volume":"7","author":"AE Vertigan","year":"2019","unstructured":"Vertigan AE, Haines J, Slovarp L (2019) An update on speech pathology management of chronic refractory cough. J Allergy Clin Immunol Pract 7(6):1756\u20131761","journal-title":"J Allergy Clin Immunol Pract"},{"key":"481_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00408-013-9508-y","volume":"192","author":"S Chamberlain","year":"2014","unstructured":"Chamberlain S, Birring SS, Garrod R (2014) Nonpharmacological interventions for refractory chronic cough patients: systematic review. Lung 192:75\u201385","journal-title":"Lung"},{"issue":"1","key":"481_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1745-9974-6-5","volume":"6","author":"NM Ryan","year":"2010","unstructured":"Ryan NM, Vertigan AE, Bone S et al (2010) Cough reflex sensitivity improves with speech language pathology management of refractory chronic cough. Cough 6(1):5","journal-title":"Cough"},{"key":"481_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/thoraxjnl-2016-208843","volume":"72","author":"SA Chamberlain Mitchell","year":"2017","unstructured":"Chamberlain Mitchell SA, Garrod R, Clark L et al (2017) Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial. Thorax 72:129\u2013136","journal-title":"Thorax"},{"issue":"1","key":"481_CR20","first-page":"103","volume":"156","author":"RS Soni","year":"2017","unstructured":"Soni RS, Ebersole B, Jamal N (2017) Treatment of chronic cough: single-institution experience utilizing behavioral therapy. OTO Open 156(1):103\u2013108","journal-title":"OTO Open"},{"issue":"12","key":"481_CR21","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1136\/thx.2006.064337","volume":"61","author":"AE Vertigan","year":"2006","unstructured":"Vertigan AE, Theodoros DG, Gibson PG et al (2006) Efficacy of speech pathology management for chronic cough: a randomised placebo controlled trial of treatment efficacy. Thorax 61(12):1065\u20131069","journal-title":"Thorax"},{"issue":"1","key":"481_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1745-9974-5-4","volume":"5","author":"NM Ryan","year":"2009","unstructured":"Ryan NM, Vertigan AE, Gibson PG (2009) Chronic cough and laryngeal dysfunction improve with specific treatment of cough and paradoxical vocal fold movement. Cough 5(1):4","journal-title":"Cough"},{"issue":"3","key":"481_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jvoice.2007.10.009","volume":"23","author":"E Hapner","year":"2009","unstructured":"Hapner E, Portone-Maira C, Johns MM (2009) A study of voice therapy dropout. J Voice 23(3):337\u2013340","journal-title":"J Voice"},{"issue":"3","key":"481_CR24","doi-asserted-by":"publisher","first-page":"336","DOI":"10.2500\/aap.2008.29.3122","volume":"29","author":"BM Levine","year":"2008","unstructured":"Levine BM (2008) Systematic evaluation and treatment of chronic cough in a community setting. Allergy Asthma Proc 29(3):336\u2013342","journal-title":"Allergy Asthma Proc"},{"issue":"10","key":"481_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/pfi.21727","volume":"56","author":"SY Chyung","year":"2017","unstructured":"Chyung SY, Roberts K, Swanson I et al (2017) Evidence-based survey design: the use of a midpoint on the likert scale. Perform Improv 56(10):15\u201323","journal-title":"Perform Improv"},{"issue":"2","key":"481_CR26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3163\/1536-5050.104.2.016","volume":"104","author":"D Cooper","year":"2016","unstructured":"Cooper D, Johnson TP (2016) How to use survey results. JMLA 104(2):174\u2013177","journal-title":"JMLA"},{"key":"481_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316771","volume-title":"Statistical intervals: a guide for practioners","author":"GJ Hahn","year":"1991","unstructured":"Hahn GJ, Meeker WQ (1991) Statistical intervals: a guide for practioners. Wiley, Hoboken"},{"key":"481_CR28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/978-3-540-79842-2_16","volume-title":"Pharmacology and therapeutics of cough","author":"AA Raj","year":"2009","unstructured":"Raj AA, Pavord DI (2009) Clinical cough IV: what is the minimal important difference for the Leicester cough questionnaire? Pharmacology and therapeutics of cough. Springer, Berlin, pp 311\u2013320"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-021-00481-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-021-00481-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-021-00481-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:10:19Z","timestamp":1634083819000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-021-00481-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["481"],"URL":"https:\/\/doi.org\/10.1007\/s00408-021-00481-3","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]},"assertion":[{"value":"18 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Miranda L. Wright: Financial: none; Non-financial: ASHA Member, ASHA SIG 3 member. Krishna M. Sundar: Non-financial (only equipment) support for study of sham vs. regular CPAP in chronic cough (Respironics Inc.); Site PI for study of iVAPS EPAP algorithm (Resmed Inc.); Co-founder, Hypnoscure LLC (no monies) through the University of Utah Technology Commercialization Office; Advisory board, Merck Inc. (on novel therapeutics for chronic refractory cough). Jennifer S. Herrick: Financial: Employed by the University of Utah and the Biostatistics Center that supported this work. Julie M. Barkmeier-Kraemer: Financial: Employed by the University of Utah, Clinic Director of the Utah Health\u00a0Voice Disorders Center; Non-financial: ASHA Member, ASHA SIG 3 member.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the University of Utah Institutional Review Board (IRB Protocol #00114102).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All participants gave consent to participate prior to completing questionnaires or telephone interviews.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have contributed to the writing of this manuscript and have reviewed the manuscript being submitted.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}